NORD Files Amicus Brief to Protect Drug Development Incentives in the Orphan Drug Act

Written by Jennifer Huron on July 30, 2015

Washington, D.C., July 30, 2015 – The National Organization for Rare Disorders (NORD) has filed an amicus brief in the D.C. Circuit of the U.S. Court of Appeals, stating that a recent Food and Drug Administration (FDA) decision has the potential to impede the development of new treatments to… Read More